openPR Logo
Press release

Malaria Vaccine Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis, 2016 and Forecast 2017 to 2023

04-02-2018 04:37 PM CET | Health & Medicine

Press release from: Precision Business Insights

Malaria Vaccine Market

Malaria Vaccine Market

Market Outline: Global Malaria Vaccine Market
Malaria is an infectious parasitic disease transmitted by a vector, female anopheles mosquito. Malaria produces recurrent attack of fever and chills. Malaria may lead to chronic conditions often death. Malaria may lead to several complications such as respiratory distress, severe headache and others. Generally, malaria is diagnosed by the blood tests by investigating symptoms and presence of parasite in blood. Malaria diseases are widely spread in tropical and subtropical regions around the equator.

Market Dynamics: Global Malaria Vaccine Market
Global malaria vaccine market is mainly driven by increase in R&D activities of companies to develop vaccines for malaria. In addition, funding of the government and non-profit organizations and presence of pipeline vaccines and their expected commercialization anticipated to bolster the market growth further. Moreover, the prevalence of malaria, especially in the developing and underdeveloped countries in Asia and Africa, projected to fuel the global malaria vaccine during forecast period. However, complexity in vaccine development and regulatory approvals coupled with the high cost are expected to hinder the market growth during the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-4H8Z4LpNMLEuOnnx


Market Scope: Global Malaria Vaccine Market
Global malaria vaccine is segmented based on type of vaccine, target and distribution channel
Based on type of vaccine, global malaria vaccine market is segmented into
• Protein Vaccine
• DNA Vaccines
• Others
Based on target, global malaria vaccines market is segmented into
• Pre-Erythrocytic Stage
• Erythrocytic Stage
• Combined Vaccines
Based on end user, global malaria vaccine market is segmented into
• Hospitals
• Vaccination Centres
• Others

Market Summary: Global Malaria Vaccine Market
Global malaria vaccine market is expected to grow at significant rates owing to prevalence rates to malaria worldwide. According to World Health Organization, in August 2015, total 91 countries and areas had ongoing malaria transmission and approximately half of the world’s population is at the risk of malaria. According to WHO estimates December 2016, 212 million cases were there in 2015. The market has only one approved malaria vaccine, Mosquirix. Mosquirix was approved in 2015 by European agency. Furthermore, pipeline vaccines such as PfSPZ Vaccine (by Sanaria) in phase 3 clinical trials and PEV 301& 302 (I phase 1b by Mymetics Corporation) and their commercialisation expected to boost the market. Government and non-government organizations initiatives are further bolstering the market growth.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-c654SbFYO64MsOhu

Regional Analysis: Global Malaria Vaccine Market
Geographically, malaria vaccine market is segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. The Middle East and Africa expected to grow at significant rates owing to the factors such as the prevalence of disease and growing awareness related to malaria vaccination, According to World Health Organization (WHO), in 2015, 90% of the malaria cases are from African Region alone. Asia Pacific region expected to have lucrative growth opportunity owing to factors such as the prevalence of the disease, growing awareness and developing healthcare infrastructure. Europe malaria vaccine expected to grow at notable rates owing to the recent product launches such as Mosquirix, presence of key market players involved in development of the malaria vaccines and prevalence of the disease in the region.

Competition Assessment: Global Malaria Vaccine Market
Some of the key players in Malaria Vaccine market are GlaxoSmithKline Plc (U.K.), Sanaria Inc. (U.S.), Mymetics Corporation (Switzerland) and Novavax, Inc. (U.S.) to name a few.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/#ulp-14mlyhjMGhVjZqa3


Notable Market Developments: Global Malaria Vaccine Market
• In June 2016, Immunovaccine Inc. announced preclinical collaboration with University of Edinburgh’s Center for Immunity, Infection and Evolution for malaria
• In January 2013, Cadila Pharmaceuticals along with its partner Novavax Inc. collaborated with CPL Biologics to develop the novel malaria vaccine.

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/malaria-vaccine-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Vaccine Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis, 2016 and Forecast 2017 to 2023 here

News-ID: 1000736 • Views:

More Releases from Precision Business Insights

Biochar Market Growth Is Attributed To The Increased Production Of Biochar Through Pyrolysis Technology
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Membrane Separation Technology
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Generation
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in